TY - JOUR AU - Theiler, J. AU - Yoon, H. AU - Yusim, K. AU - Picker, L. J. AU - Fruh, K. AU - Korber, B. PY - 2016 DA - 2016// TI - Epigraph: a vaccine design tool applied to an HIV therapeutic vaccine and a pan-filovirus vaccine JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep33987 DO - 10.1038/srep33987 ID - Theiler2016 ER - TY - JOUR AU - Chen, J. AU - Kovacs, J. M. AU - Peng, H. AU - Rits-Volloch, S. AU - Lu, J. AU - Park, D. PY - 2015 DA - 2015// TI - HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein JO - Science VL - 349 UR - https://doi.org/10.1126/science.aaa9804 DO - 10.1126/science.aaa9804 ID - Chen2015 ER - TY - JOUR AU - Sanders, R. W. AU - Derking, R. AU - Cupo, A. AU - Julien, J. P. AU - Yasmeen, A. AU - Val, N. PY - 2013 DA - 2013// TI - A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies JO - PLoS Pathog VL - 9 UR - https://doi.org/10.1371/journal.ppat.1003618 DO - 10.1371/journal.ppat.1003618 ID - Sanders2013 ER - TY - JOUR AU - Stewart-Jones, G. B. AU - Soto, C. AU - Lemmin, T. AU - Chuang, G. Y. AU - Druz, A. AU - Kong, R. PY - 2016 DA - 2016// TI - Trimeric HIV-1-Env structures define Glycan shields from clades A, B, and G JO - Cell VL - 165 UR - https://doi.org/10.1016/j.cell.2016.04.010 DO - 10.1016/j.cell.2016.04.010 ID - Stewart-Jones2016 ER - TY - JOUR AU - Stephenson, K. E. AU - D’Couto, H. T. AU - Barouch, D. H. PY - 2016 DA - 2016// TI - New concepts in HIV-1 vaccine development JO - Curr Opin Immunol VL - 41 UR - https://doi.org/10.1016/j.coi.2016.05.011 DO - 10.1016/j.coi.2016.05.011 ID - Stephenson2016 ER - TY - JOUR AU - Mylvaganam, G. H. AU - Silvestri, G. AU - Amara, R. R. PY - 2015 DA - 2015// TI - HIV therapeutic vaccines: moving towards a functional cure JO - Curr Opin Immunol VL - 35 UR - https://doi.org/10.1016/j.coi.2015.05.001 DO - 10.1016/j.coi.2015.05.001 ID - Mylvaganam2015 ER - TY - STD TI - C.Yong Kang, Yong Gao. Killed Whole-HIV Vaccine; A New Approach for HIV Vaccine Development Employing One of Well Established Strategies for Antiviral Vaccines. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0176-5. ID - ref7 ER - TY - STD TI - Yousuf Ahmed, Meijuan Tian, Yong Gao. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0178-3. ID - ref8 ER - TY - STD TI - Trina Racine, Gary P Kobinger, Eric J Arts. Development of an HIV vaccine using a ve 1 sicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral response. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0179-2. ID - ref9 ER - TY - STD TI - Jonathan Richard, Shilei Ding, Andres Finzi. Unlocking HIV-1 Env: implications for antibody attack. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0168-5. ID - ref10 ER - TY - STD TI - Jun Liu, Mario Ostrowski. Development of 1 targeted adjuvants for HIV-1 vaccines. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0165-8. ID - ref11 ER - TY - STD TI - Gregory A Dekaban, Jimmy D Dikeakos. HIV-I Nef inhibitors: A novel class of HIV-specifc immune adjuvants in support of a cure. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0175-6. ID - ref12 ER - TY - STD TI - Hongzhao Li, Robert W Omange, Francis A Plummer, Ma Luo. A novel HIV vaccine targeting the protease cleavage sites. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0174-7. ID - ref13 ER - TY - STD TI - Kayla A Holder, Michael D Grant. Modulation of the strength and character of HIV-1 specific CD8+ T cell responses with heteroclitic peptides. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0170-y. ID - ref14 ER - TY - STD TI - Michael D Grant, Mani Larijani. Evasion of adaptive immunity by HIV through the action of host-restriction factors. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0173-8. ID - ref15 ER - TY - STD TI - Joshua Pankrac, Katja Klein, Jamie FS Mann. Eradication of HIV-1 latent reservoirs t 1 hrough therapeutic vaccination. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0177-4. ID - ref16 ER - TY - STD TI - Amy E Baxter, Julia Niessl, Antigoni Morou, Daniel E Kaufmann. RNA Flow Cytometric FISH For Investigations into HIV Immunology, Vaccination and Cure Strategies. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0171-x. ID - ref17 ER - TY - STD TI - Jessica L.Prodger, Rupert Kaul. The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0167-6. ID - ref18 ER - TY - STD TI - Jean-Pierre Routy, Vikram Mehra. Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0164-9. ID - ref19 ER - TY - STD TI - Nicole F Bernard. Natural Killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: Investigation of how protective genotypes influence anti-HIV NK cell functions. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0172-9. ID - ref20 ER - TY - STD TI - Julie Lajoie, Lucy Mwangi, Keith R Fowke. Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0166-7. ID - ref21 ER - TY - STD TI - Danielle Vitali, Jocelyn M Wessels, Charu Kaushic. Role of sex hormones and the vaginal microbiome in susceptibility a 1 nd mucosal immunity to HIV-1 in the female genital tract. AIDS Res Ther. 2017;14. doi:10.1186/s12981-017-0169-4. ID - ref22 ER -